Cargando…
Prevalence of ABCC3‐1767G/A polymorphism among patients with antiretroviral‐associated hepatotoxicity
BACKGROUND: Plasma concentrations of antiretrovirals (ARVs) regimens have considerably varied in individuals of human immunodeficiency virus (HIV) because of variations in the expression of drug‐metabolizing and transporter genes. Transporter genes play an important role in the disposition of drugs....
Autores principales: | Singh, HariOm, Lata, Sonam, Choudhari, Ranjana, Dhole, Tapan N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284032/ https://www.ncbi.nlm.nih.gov/pubmed/32212330 http://dx.doi.org/10.1002/mgg3.1124 |
Ejemplares similares
-
Occurrence of CYP2B6 516G>T polymorphism in patients with ARV‐associated hepatotoxicity
por: Singh, HariOm, et al.
Publicado: (2019) -
Polymorphisms in miRNAs Gene (146a, 149, 196a) and Susceptibility to ARV-associated Hepatotoxicity
por: Singh, Hari Om, et al.
Publicado: (2019) -
ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease
por: Singh, HariOm, et al.
Publicado: (2021) -
IL-1RN and IL-1β Polymorphism and ARV-Associated Hepatotoxicity
por: Singh, HariOm, et al.
Publicado: (2018) -
TLR7 Polymorphism (rs179008 and rs179009) in HIV-Infected Individual Naïve to ART
por: Singh, HariOm, et al.
Publicado: (2020)